Abdulrahman Alahmari

9PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Neoadjuvant PD-1-Based Immunotherapy in Localized dMMR/MSI-H Colorectal Cancer: A Systematic Review and Arm-Based Meta-Analysis.

|May 12, 2026
The Colorectal Cancer Glycocode: Tumour Sialylation Is Associated with an Immune-Excluded Phenotype and Distinct Therapeutic Signatures.

|May 12, 2026
Fucosylation Dynamics as a Critical Determinant of Cancer Cell Fate in Colorectal Carcinoma: Integrating Hallmark Plasticity, Microenvironmental Remodelling, and Therapeutic Resistance.

|Mar 28, 2026
Comparative Clinicopathological Features and p16 Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Cervix: A Single-Center Retrospective Cohort Study in Saudi Arabia (2020-2024).

Emad Alqassim, Mashael J Abu Alola, Ahmad Y Alqassim

|Dec 30, 2025
CPSF1 Is Co-Amplified with MYC but Is Independently Associated with Alternative Polyadenylation in Cancer.

Abdulrahman A Alahmari

|Jan 08, 2024
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.

Abdulrahman A Alahmari, Aditi H Chaubey, Venkata S Jonnakuti

Pageof 2

Frequent Collaborators

2 joint publications

Swati Venkat

2 joint publications

Michael E Feigin

2 joint publications

Glowi Alasiri

2 joint publications

Abdulaziz Alfahed